Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost of Manufacturing for Recombinant Snakebite Antivenoms
Timothy P. Jenkins, Andreas H. Laustsen
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

De novo designed proteins neutralize lethal snake venom toxins
Susana Vázquez Torres, Melisa Bénard-Valle, Stephen P. Mackessy, et al.
Nature (2025) Vol. 639, Iss. 8053, pp. 225-231
Open Access | Times Cited: 10
Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes
Line Ledsgaard, Jack Wade, Timothy P. Jenkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model
Melisa Bénard-Valle, Yessica Wouters, Anne Ljungars, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers
Samuel Odo Uko, Ibrahim Malami, Kasimu Ghandi Ibrahim, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25531-e25531
Open Access | Times Cited: 8
Genetic variability in snake venom and its implications for antivenom development in sub-Saharan Africa
Innocent Ayesiga, Lenz Nwachinemere Okoro, Chirigo Taremba, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Closed Access | Times Cited: 1
Target product profiles for pan-Africa recombinant antivenoms against neurotoxic or hemotoxic and cytotoxic snakebite envenoming
Andreas H. Laustsen, Melisa Bénard-Valle, Abdulrazaq G. Habib, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 1, pp. e0012833-e0012833
Open Access | Times Cited: 1
Clinical management of snakebite envenoming: Future perspectives
Muhammad Hamza, Cecilie Knudsen, Christeine Ariaranee Gnanathasan, et al.
Toxicon X (2021) Vol. 11, pp. 100079-100079
Open Access | Times Cited: 45
In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom
Line Ledsgaard, Andreas H. Laustsen, Urška Puš, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Snakebite Treatment in Tanzania: Identifying Gaps in Community Practices and Hospital Resources
Felicia Margono, Anne H. Outwater, Michael Lowery Wilson, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4701-4701
Open Access | Times Cited: 25
Antibodies as Snakebite Antivenoms: Past and Future
Wilmar Dias da Silva, Sonia Aparecida de Andrade, Ângela Alice Amadeu Megale, et al.
Toxins (2022) Vol. 14, Iss. 9, pp. 606-606
Open Access | Times Cited: 23
Recent advancements in snake antivenom production
Anurag S. Rathore, Ramesh Kumar, Om Shanker Tiwari
International Journal of Biological Macromolecules (2023) Vol. 240, pp. 124478-124478
Closed Access | Times Cited: 14
Diagnostic platforms for snakebite: current approaches and challenges in medically important species
Nairo Brilhante-da-Silva, Sibele Andrade Roberto, Nidiane Dantas Reis Prado, et al.
Analytical Biochemistry (2025), pp. 115823-115823
Closed Access
Terrestrial venomous animals, the envenomings they cause, and treatment perspectives in the Middle East and North Africa
Timothy P. Jenkins, Shirin Ahmadi, Mátyás A. Bittenbinder, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 12, pp. e0009880-e0009880
Open Access | Times Cited: 29
The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy
Gayathri Gopal, Shibi Muralidar, Diwahar Prakash, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124771-124771
Closed Access | Times Cited: 12
Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies
Suthimon Thumtecho, Nick J. Burlet, Anne Ljungars, et al.
˜The œJournal of venomous animals and toxins including tropical diseases (2023) Vol. 29
Open Access | Times Cited: 12
Phage display technology and its impact in the discovery of novel protein-based drugs
Catherine J. Hutchings, Aaron K. Sato
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 887-915
Open Access | Times Cited: 4
Therapeutic Potential of Biotoxins and Biotechnological Innovations
Prince Kumar Singh, Gereraj Sen Gupta, Indrajeet Kumar, et al.
(2025), pp. 381-410
Closed Access
De novo designed proteins neutralize lethal snake venom toxins
David Baker, Susana Vázquez Torres, Melisa Benard Valle, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
Nessrin Alomran, Patricia A. Blundell, Jaffer Alsolaiss, et al.
Toxins (2022) Vol. 14, Iss. 7, pp. 443-443
Open Access | Times Cited: 14
Engineering of single-domain antibodies for next-generation snakebite antivenoms
Carla Freire Celedônio Fernandes, Soraya dos Santos Pereira, Marcos Barros Luiz, et al.
International Journal of Biological Macromolecules (2021) Vol. 185, pp. 240-250
Closed Access | Times Cited: 19
Single‐Batch Expression of an Experimental Recombinant Snakebite Antivenom Based on an Oligoclonal Mixture of Human Monoclonal Antibodies
Anna Christina Adams, Lise Marie Grav, Shirin Ahmadi, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 2
Identification of Daboia siamensis venome using integrated multi-omics data
Thammakorn Saethang, Poorichaya Somparn, Sunchai Payungporn, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Exploring the utility of recombinantly expressed snake venom serine protease toxins as immunogens for generating experimental snakebite antivenoms
Nessrin Alomran, Patricia A. Blundell, Jaffer Alsolaiss, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment
Natalie M Morris, Johanna A. Blee, Sabine Hauert
Toxicon (2022) Vol. 215, pp. 77-90
Open Access | Times Cited: 7
Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite Antivenoms
Marcela Cristina S. Silva, Soraya dos Santos Pereira, Marilia P. Gouveia, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top